ID

41608

Description

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 14.10.2020, 16:17 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS is mandated by the ESCMID Emerging Infections Task Force (EITaF) and supported by the German Infectious Disease Society. It aims at a better understanding of the implications of the new virus on patients by systematically documenting patient data across Europe (Text adapted from leoss.net). For more information please visit the official website. This document is for Uncomplicated Phase data. Please note that only cases with known outcome are collected at LEOSS! At Day , your patient has entered the Uncomplicated Phase of disease. All questions below ask you to aggregate over the whole time of the Uncomplicated Phase, which often ends with need for oxygen. Remember: The Uncomplicated Phase ends, if a previously febrile patient has no fever anymore and has completed 14 days of follow-up without entering Complicated or Critical Phase; then move to Recovery Phase. Also, as soon as one of the criteria of the Complicated or Critical Phase are fulfilled, Uncomplicated Phase ends; move over to there. If the patient has died, the phase ends with the death of the patient. If the patient has died, do not report terminal values, e.g. those recorded after switching off life-support or heart rate "0" after death of the patient. Criteria of the Uncomplicated Phase: Asymptomatic OR Symptoms of upper respiratory tract infection and/or Nausea, emesis, diarrhea and/or Fever If a text field can't be filled out, note 'ND' (for not determined)

Link

https://leoss.net

Keywords

Versions (2)
  1. 11/25/20 11/25/20 -
  2. 6/15/21 6/15/21 -
Copyright Holder

LEOSS

Uploaded on

November 25, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

English

Uncomplicated Phase

1 forms  
  1. StudyEvent: ODM
    1. Uncomplicated Phase
Feeling of breathlessness
Description

Feeling of breathlessness

Alias
UMLS CUI-1
C0013404
Feeling of breathlessness
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1]
C0013404
Chest CT results:
Description

Chest CT results:

Alias
UMLS CUI-1
C0202823
UMLS CUI-2
C1274040
Air trapping
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0231819
UMLS CUI [1,2]
C0202823
Areas of consolidation
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0521530
UMLS CUI [1,2]
C0202823
Bronchiolitis
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0006271
UMLS CUI [1,2]
C0202823
Crazy paving pattern
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C4476749
Ground glass opacities
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C3827002
UMLS CUI [1,2]
C0202823
Interlobular septal thickening
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C4280727
Nodulary lesions
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C1518345
UMLS CUI [1,2]
C0202823
Pleural effusion
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0032227
UMLS CUI [1,2]
C0202823
Chest x-ray results
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0039985
Chest x-ray results, please specify (short description: no copy & paste)
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

text

Alias
UMLS CUI [1,1]
C0039985
UMLS CUI [1,2]
C1521902
Other relevant CT results
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C1274040
UMLS CUI [1,3]
C2347946
UMLS CUI [1,4]
C0202823
If Other relevant CT results, please specify (short description: no copy & paste)
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C1274040
UMLS CUI [1,3]
C2347946
UMLS CUI [1,4]
C1521902
UMLS CUI [1,5]
C0202823
Normal CT
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0205307
UMLS CUI [1,2]
C0202823
Not done
Description

Note: This question is critical for the further course of the questionnaire. Worst results from all CTs during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C1272696
UMLS CUI [1,2]
C0202823
Treatments received, Antivirals
Description

Treatments received, Antivirals

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0280274
Atazanavir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C1145759
Darunavir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C1435444
Chloroquine phosphate
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0055447
Hydroxychloroquine
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0020336
Ivermectin
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0022322
Lopinavir/ritonavir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0674432
UMLS CUI [2]
C0292818
Maraviroc
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C1667052
Ganciclovir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0017066
Oseltamivir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0874161
Remdesivir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C4726677
Ribavirin
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0035525
Camostat
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0129975
Favipiravir
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C1138226
Treatments received, Antibacterial prophylaxis (just primary prevention not treatment for diagnosed bacterial infections)
Description

Treatments received, Antibacterial prophylaxis (just primary prevention not treatment for diagnosed bacterial infections)

Alias
UMLS CUI-1
C0279516
UMLS CUI-2
C0199176
Betalactams (penicillins, cephalosporines, carbapenems)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0006968
UMLS CUI [2]
C0030842
UMLS CUI [3]
C3536856
Azithromycin
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0052796
Other macrolide (erythromycin, clarithromycin, roxithromycin)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0282563
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C0035891
UMLS CUI [3]
C0014806
UMLS CUI [4]
C0055856
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0949665
UMLS CUI [2]
C0282386
UMLS CUI [3]
C0536495
UMLS CUI [4]
C0008809
Treatments received, Antifungals
Description

Treatments received, Antifungals

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0003308
Itraconazole
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0064113
Posaconazole
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0936148
Other systemically active antifungals
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0003308
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C1515119
Treatments received, Immunosuppressants
Description

Treatments received, Immunosuppressants

Alias
UMLS CUI-1
C0021081
UMLS CUI-2
C0087111
Steroids > 0.5 mg/kg prednisone equivalents
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0178602
Steroids <= 0.5 mg/kg prednisone equivalents
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0445550
IL-6-receptor antagonist (tocilizumab)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C3819026
UMLS CUI [2]
C1609165
CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C1562036
UMLS CUI [2]
C2746052
UMLS CUI [3]
C0541315
UMLS CUI [4]
C0072980
UMLS CUI [5]
C0010592
UMLS CUI [6]
C0085149
Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C3653350
UMLS CUI [2]
C1122087
UMLS CUI [3]
C0717758
Il1-receptor antagonists
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C2917260
Ruxolitinib (JAK inhibitors)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C2931926
UMLS CUI [2]
C3854325
Treatments received, Heart / circulatory medication
Description

Treatments received, Heart / circulatory medication

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0007226
UMLS CUI-3
C0013227
ACE inhibitors (e.g. enalapril, captopril, most drugs ending on -pril)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0003015
UMLS CUI [2]
C0006938
UMLS CUI [3]
C0014025
Betablockers (e.g. bisoprolol, metoprolol, most drugs ending on -prolol)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0053799
UMLS CUI [2]
C0025859
UMLS CUI [3]
C0304516
AT-II-receptor-1-antagonists (e.g. candesartan, losartan, most drugs ending on -sartan)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0521942
UMLS CUI [2]
C0126174
UMLS CUI [3]
C0717550
Other antihypertensives
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C0205394
Statines (e.g. atorvastatin, pravastatin, most drugs ending on -statin)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0286651
UMLS CUI [2]
C0085542
UMLS CUI [3]
C0360714
Anti-arrhythmics (e.g. digitoxine, verapamil)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0003195
UMLS CUI [2]
C0042523
UMLS CUI [3]
C0012258
Adrenaline or other sympathomimetics (e.g. noradrenaline, dobutamine, epinephrine)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0014563
UMLS CUI [2]
C0012963
UMLS CUI [3]
C0028351
UMLS CUI [4,1]
C0205394
UMLS CUI [4,2]
C0039052
Vasopressin (e.g. argipressin, arginine vasopressin)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0042413
UMLS CUI [2]
C0003779
Iloprost
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0079594
Nitrates (nitroglycerin, ISMN, Molsidomin, NO)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C3654024
UMLS CUI [2]
C0017887
UMLS CUI [3]
C0064079
UMLS CUI [4]
C0026400
UMLS CUI [5]
C0028215
Aviptadil (VIP analog)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C1098515
UMLS CUI [2,1]
C0042395
UMLS CUI [2,2]
C0243071
Colchicine
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0009262
Treatments received, Immune therapy
Description

Treatments received, Immune therapy

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0279021
Immunoglobulines
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0021027
Interferone (any)
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0021747
Apheresis therapy
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0005791
Vitamin D
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0042866
Zinc
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1]
C0043481
Convalescent plasma
Description

Note: This question is critical for the further course of the questionnaire. All drugs in the context of the SARS-CoV-2 infection and administered at least once during this phase of disease.

Data type

integer

Alias
UMLS CUI [1,1]
C0032105
UMLS CUI [1,2]
C0740326
Other COVID-19 related drug therapy
Description

Other COVID-19 related drug therapy

Alias
UMLS CUI-1
C5203670
UMLS CUI-2
C0087111
UMLS CUI-3
C0205394
Other COVID-19 related drug therapy
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
If Other COVID-19 related drug therapy, please specify
Description

Note: This question is critical for the further course of the questionnaire.

Data type

text

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C1521902
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Non-oral anticoagulants
Description

Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Non-oral anticoagulants

Alias
UMLS CUI-1
C0199242
UMLS CUI-2
C0032177
UMLS CUI-3
C0003280
UMLS CUI-4
C1518896
Heparin, prophylactic dose
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0199176
Heparin, therapeutic dose
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0302350
Heparin, subtherapeutic dose (but higher than prophylactic dose)
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205103
UMLS CUI [1,4]
C0199176
UMLS CUI [1,5]
C0302350
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), prophylactic dose
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0019139
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0199176
UMLS CUI [2,1]
C0206460
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0199176
UMLS CUI [3,1]
C0878354
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0199176
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), therapeutic dose
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0019139
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0302350
UMLS CUI [2,1]
C0206460
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0302350
UMLS CUI [3,1]
C0878354
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0302350
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), subtherapeutic dose (but higher than prophylactic dose)
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0019139
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205103
UMLS CUI [1,4]
C0199176
UMLS CUI [1,5]
C0302350
UMLS CUI [2,1]
C0206460
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205103
UMLS CUI [2,4]
C0199176
UMLS CUI [2,5]
C0302350
UMLS CUI [3,1]
C0878354
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205103
UMLS CUI [3,4]
C0199176
UMLS CUI [3,5]
C0302350
Argatroban
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1]
C0048470
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Oral anticoagulants
Description

Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Oral anticoagulants

Alias
UMLS CUI-1
C0199242
UMLS CUI-2
C0032177
UMLS CUI-3
C0354604
Warfarin / marcumar
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1]
C0043031
UMLS CUI [2]
C0918269
New / direct oral anticoagulants (rivaroxaban, apixaban, dabigatran)
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0360593
UMLS CUI [1,2]
C0442027
UMLS CUI [2]
C1739768
UMLS CUI [3]
C1831808
UMLS CUI [4]
C2348066
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Platelet aggregation inhibition
Description

Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Platelet aggregation inhibition

Alias
UMLS CUI-1
C0199242
UMLS CUI-2
C0032177
Aspirin
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1]
C0004057
ADP receptor inhibitors (Clopidogrel, Cangrelor, Ticagrelor)
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1]
C1373149
UMLS CUI [2]
C0070166
UMLS CUI [3]
C1121991
UMLS CUI [4]
C1999375
Glycoprotein IIB/IIIA inhibitors
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1]
C1373125
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Further anticoagulation / platelet aggregation inhibition
Description

Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Further anticoagulation / platelet aggregation inhibition

Alias
UMLS CUI-1
C0199242
UMLS CUI-2
C0003281
UMLS CUI-3
C0032177
Other
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0003280
If Other, please specify
Description

Other, specify

Data type

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0003280
UMLS CUI [1,3]
C1521902
None
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0549184
UMLS CUI [1,2]
C0003281
Unknown
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0439673
UMLS CUI [1,2]
C0003281
Vital signs and respiratory parameters
Description

Vital signs and respiratory parameters

Alias
UMLS CUI-1
C0518766
UMLS CUI-2
C0035237
UMLS CUI-3
C0549193
Worst during uncomplicated phase: Systolic BP
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0871470
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: Diastolic BP
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0428883
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: Pulse
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0232117
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: SO2
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0523807
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: paO2
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0202155
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: paCO2
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C1822070
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: Temperature
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0039476
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: Respiratory rate / minute
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0231832
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Worst during uncomplicated phase: Glasgow Coma scale
Description

Note: This question is critical for the further course of the questionnaire. Worst means farthest from normal range.

Data type

integer

Alias
UMLS CUI [1,1]
C0017594
UMLS CUI [1,2]
C1522166
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Super-Infections
Description

Super-Infections

Alias
UMLS CUI-1
C0038826
Proven bacterial infection:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

integer

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0456369
Proven bacterial infection, please specify:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

text

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0456369
UMLS CUI [1,3]
C1521902
Probable or suspected bacterial infection:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

integer

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0332147
Probable or suspected bacterial infection, please specify:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

text

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0332147
UMLS CUI [1,3]
C1521902
Proven fungal infection:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

integer

Alias
UMLS CUI [1,1]
C0026946
UMLS CUI [1,2]
C0456369
Proven fungal infection, please specify:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

text

Alias
UMLS CUI [1,1]
C0026946
UMLS CUI [1,2]
C0456369
UMLS CUI [1,3]
C1521902
Probable or suspected fungal infection:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

integer

Alias
UMLS CUI [1,1]
C0026946
UMLS CUI [1,2]
C0332147
Probable or suspected fungal infection, please specify:
Description

Note: This question is critical for the further course of the questionnaire. Pleaase fill in the site and respecitve patogen if available. Please note if it is a co-infection (co-infection).

Data type

text

Alias
UMLS CUI [1,1]
C0026946
UMLS CUI [1,2]
C0332147
UMLS CUI [1,3]
C1521902
None
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0549184
UMLS CUI [1,2]
C0038826
Unknown
Description

Note: This question is critical for the further course of the questionnaire.

Data type

integer

Alias
UMLS CUI [1,1]
C0439673
UMLS CUI [1,2]
C0038826
Antibacterial treatment: Betalactams
Description

Antibacterial treatment: Betalactams

Alias
UMLS CUI-1
C0279516
UMLS CUI-2
C0087111
UMLS CUI-3
C0282215
Penicillins/ aminopenicilins
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0030842
UMLS CUI [2]
C0304324
Cephalosporins I-III
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0304317
UMLS CUI [2]
C0304319
UMLS CUI [3]
C0304320
Carbapenems (meropenem, imipenem, ertapenem, doripenem)
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0006968
UMLS CUI [2]
C0066005
UMLS CUI [3]
C0020933
UMLS CUI [4]
C1120106
UMLS CUI [5]
C0389169
Piperacillin/tazobactam
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0250480
New betalactams for multi-resistent bacteria (ceftazidime/avibactam, ceftolozane/tazobactam, cefiderocol)
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1,1]
C0205314
UMLS CUI [1,2]
C0282215
UMLS CUI [1,3]
C3826980
UMLS CUI [2]
C3656596
UMLS CUI [3]
C3656593
UMLS CUI [4]
C4548369
Antibacterial treatment: Macrolides
Description

Antibacterial treatment: Macrolides

Alias
UMLS CUI-1
C0279516
UMLS CUI-2
C0087111
UMLS CUI-3
C0003240
Azithromycin
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0052796
Other macrolide (erythromycin, clarithromycin, roxithromycin)
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1,1]
C0003240
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C0014806
UMLS CUI [3]
C0055856
UMLS CUI [4]
C0035891
Antibacterial treatment: Other antibacterial treatment
Description

Antibacterial treatment: Other antibacterial treatment

Alias
UMLS CUI-1
C0279516
UMLS CUI-2
C0087111
UMLS CUI-3
C0205394
Glycopeptides (vancomycin, teicoplanin)
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0017953
UMLS CUI [2]
C0042313
UMLS CUI [3]
C0145106
Other gram-positive active drugs for multiresistant bacteria (e.g. linezolid, daptomycin)
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C00032332
UMLS CUI [1,3]
C0018154
UMLS CUI [1,4]
C3826980
UMLS CUI [2]
C0663241
UMLS CUI [3]
C0057144
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1]
C0034428
UMLS CUI [2]
C0008809
UMLS CUI [3]
C0536495
UMLS CUI [4]
C0282386
Other
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

integer

Alias
UMLS CUI [1,1]
C0279516
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
If Other, please specify
Description

Note: This question is critical for the further course of the questionnaire. Please indicate all antibacterials administered at least once for antibacterial treatment during this phase. Please note that antibacterial prophylaxis should not be mentioned here.

Data type

text

Alias
UMLS CUI [1,1]
C0279516
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C1521902
Is data entry for this section finished?
Description

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Description

BL_Completed

Data type

integer

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197
Back to the top of the page

Similar models

Uncomplicated Phase

1 forms
  1. StudyEvent: ODM
    1. Uncomplicated Phase
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Feeling of breathlessness
C0013404 (UMLS CUI-1)
Item
Feeling of breathlessness
integer
C0013404 (UMLS CUI [1])
CO_Breathlessness
Code List
Feeling of breathlessness
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
None (4)
CL Item
Unknown (5)
Item Group
Chest CT results:
C0202823 (UMLS CUI-1)
C1274040 (UMLS CUI-2)
Item
Air trapping
integer
C0231819 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Air trapping
Code List
Air trapping
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Areas of consolidation
integer
C0521530 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Areas of consolidation
Code List
Areas of consolidation
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Bronchiolitis
integer
C0006271 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Bronchiolitis
Code List
Bronchiolitis
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Crazy paving pattern
integer
C4476749 (UMLS CUI [1])
Bronchiolitis
Code List
Crazy paving pattern
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Ground glass opacities
integer
C3827002 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Ground glass opacities
Code List
Ground glass opacities
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Interlobular septal thickening
integer
C4280727 (UMLS CUI [1])
Ground glass opacities
Code List
Interlobular septal thickening
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Nodulary lesions
integer
C1518345 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Nodulary lesions
Code List
Nodulary lesions
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Pleural effusion
integer
C0032227 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Pleural effusion
Code List
Pleural effusion
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Chest x-ray results
integer
C0039985 (UMLS CUI [1])
Other relevant results, short description (do not copy & paste):
Code List
Chest x-ray results
CL Item
not quoted (0)
CL Item
quoted (1)
Chest x-ray - specify
Item
Chest x-ray results, please specify (short description: no copy & paste)
text
C0039985 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
Item
Other relevant CT results
integer
C0205394 (UMLS CUI [1,1])
C1274040 (UMLS CUI [1,2])
C2347946 (UMLS CUI [1,3])
C0202823 (UMLS CUI [1,4])
Other relevant results, short description (do not copy & paste):
Code List
Other relevant CT results
CL Item
not quoted (0)
CL Item
quoted (1)
Other relevant chest CT results - specify
Item
If Other relevant CT results, please specify (short description: no copy & paste)
text
C0205394 (UMLS CUI [1,1])
C1274040 (UMLS CUI [1,2])
C2347946 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
C0202823 (UMLS CUI [1,5])
Item
Normal CT
integer
C0205307 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Normal CT
Code List
Normal CT
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Not done
integer
C1272696 (UMLS CUI [1,1])
C0202823 (UMLS CUI [1,2])
Not done
Code List
Not done
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Treatments received, Antivirals
C0087111 (UMLS CUI-1)
C0280274 (UMLS CUI-2)
Item
Atazanavir
integer
C1145759 (UMLS CUI [1])
Atazanavir
Code List
Atazanavir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Darunavir
integer
C1435444 (UMLS CUI [1])
Darunavir
Code List
Darunavir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Chloroquine phosphate
integer
C0055447 (UMLS CUI [1])
Chloroquine phosphate
Code List
Chloroquine phosphate
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Hydroxychloroquine
integer
C0020336 (UMLS CUI [1])
Hydroxychloroquine
Code List
Hydroxychloroquine
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ivermectin
integer
C0022322 (UMLS CUI [1])
Ivermectin
Code List
Ivermectin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Lopinavir/ritonavir
integer
C0674432 (UMLS CUI [1])
C0292818 (UMLS CUI [2])
Lopinavir/ritonavir
Code List
Lopinavir/ritonavir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Maraviroc
integer
C1667052 (UMLS CUI [1])
Lopinavir/ritonavir
Code List
Maraviroc
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ganciclovir
integer
C0017066 (UMLS CUI [1])
Ganciclovir
Code List
Ganciclovir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Oseltamivir
integer
C0874161 (UMLS CUI [1])
Oseltamivir
Code List
Oseltamivir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Remdesivir
integer
C4726677 (UMLS CUI [1])
Remdesivir
Code List
Remdesivir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ribavirin
integer
C0035525 (UMLS CUI [1])
Ribavirin
Code List
Ribavirin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Camostat
integer
C0129975 (UMLS CUI [1])
Camostat
Code List
Camostat
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Favipiravir
integer
C1138226 (UMLS CUI [1])
Favipiravir
Code List
Favipiravir
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Treatments received, Antibacterial prophylaxis (just primary prevention not treatment for diagnosed bacterial infections)
C0279516 (UMLS CUI-1)
C0199176 (UMLS CUI-2)
Item
Betalactams (penicillins, cephalosporines, carbapenems)
integer
C0006968 (UMLS CUI [1])
C0030842 (UMLS CUI [2])
C3536856 (UMLS CUI [3])
Betalactams (penicillins, cephalosporines, carbapenems)
Code List
Betalactams (penicillins, cephalosporines, carbapenems)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Azithromycin
integer
C0052796 (UMLS CUI [1])
Azithromycin
Code List
Azithromycin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other macrolide (erythromycin, clarithromycin, roxithromycin)
integer
C0282563 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0035891 (UMLS CUI [2])
C0014806 (UMLS CUI [3])
C0055856 (UMLS CUI [4])
Other macrolide (erythromycin, clarithromycin, roxithromycin)
Code List
Other macrolide (erythromycin, clarithromycin, roxithromycin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
integer
C0949665 (UMLS CUI [1])
C0282386 (UMLS CUI [2])
C0536495 (UMLS CUI [3])
C0008809 (UMLS CUI [4])
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
Code List
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Treatments received, Antifungals
C0087111 (UMLS CUI-1)
C0003308 (UMLS CUI-2)
Item
Itraconazole
integer
C0064113 (UMLS CUI [1])
Itraconazole
Code List
Itraconazole
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Posaconazole
integer
C0936148 (UMLS CUI [1])
Posaconazole
Code List
Posaconazole
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other systemically active antifungals
integer
C0003308 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
Other systemically active antifungals
Code List
Other systemically active antifungals
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Treatments received, Immunosuppressants
C0021081 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
Item
Steroids > 0.5 mg/kg prednisone equivalents
integer
C0038317 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Steroids > 0.5 mg/kg prednisone equivalents
Code List
Steroids > 0.5 mg/kg prednisone equivalents
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Steroids <= 0.5 mg/kg prednisone equivalents
integer
C0038317 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0445550 (UMLS CUI [1,3])
Steroids <= 0.5 mg/kg prednisone equivalents
Code List
Steroids <= 0.5 mg/kg prednisone equivalents
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
IL-6-receptor antagonist (tocilizumab)
integer
C3819026 (UMLS CUI [1])
C1609165 (UMLS CUI [2])
Tocilizumab
Code List
IL-6-receptor antagonist (tocilizumab)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
integer
C1562036 (UMLS CUI [1])
C2746052 (UMLS CUI [2])
C0541315 (UMLS CUI [3])
C0072980 (UMLS CUI [4])
C0010592 (UMLS CUI [5])
C0085149 (UMLS CUI [6])
CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
Code List
CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
integer
C3653350 (UMLS CUI [1])
C1122087 (UMLS CUI [2])
C0717758 (UMLS CUI [3])
Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
Code List
Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Il1-receptor antagonists
integer
C2917260 (UMLS CUI [1])
Il1-receptor antagonists
Code List
Il1-receptor antagonists
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ruxolitinib (JAK inhibitors)
integer
C2931926 (UMLS CUI [1])
C3854325 (UMLS CUI [2])
Ruxolitinib
Code List
Ruxolitinib (JAK inhibitors)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Treatments received, Heart / circulatory medication
C0087111 (UMLS CUI-1)
C0007226 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
Item
ACE inhibitors (e.g. enalapril, captopril, most drugs ending on -pril)
integer
C0003015 (UMLS CUI [1])
C0006938 (UMLS CUI [2])
C0014025 (UMLS CUI [3])
ACE inhibitors (e.g. elanapril, captopril, most drugs ending on -pril)
Code List
ACE inhibitors (e.g. enalapril, captopril, most drugs ending on -pril)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Betablockers (e.g. bisoprolol, metoprolol, most drugs ending on -prolol)
integer
C0053799 (UMLS CUI [1])
C0025859 (UMLS CUI [2])
C0304516 (UMLS CUI [3])
Betablockers (e.g. bisoprolol, metoprolol, most drugs ending on -prolol)
Code List
Betablockers (e.g. bisoprolol, metoprolol, most drugs ending on -prolol)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
AT-II-receptor-1-antagonists (e.g. candesartan, losartan, most drugs ending on -sartan)
integer
C0521942 (UMLS CUI [1])
C0126174 (UMLS CUI [2])
C0717550 (UMLS CUI [3])
AT-II inhibitors (e.g. candesartan, losartan, most drugs ending on -sartan)
Code List
AT-II-receptor-1-antagonists (e.g. candesartan, losartan, most drugs ending on -sartan)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other antihypertensives
integer
C0003364 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Other antihypertensives
Code List
Other antihypertensives
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Statines (e.g. atorvastatin, pravastatin, most drugs ending on -statin)
integer
C0286651 (UMLS CUI [1])
C0085542 (UMLS CUI [2])
C0360714 (UMLS CUI [3])
Statines (e.g. atorvastatin, pravastatin, most drugs ending on -statin)
Code List
Statines (e.g. atorvastatin, pravastatin, most drugs ending on -statin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Anti-arrhythmics (e.g. digitoxine, verapamil)
integer
C0003195 (UMLS CUI [1])
C0042523 (UMLS CUI [2])
C0012258 (UMLS CUI [3])
Anti-arrhythmics (e.g. digitoxine, verapamil)
Code List
Anti-arrhythmics (e.g. digitoxine, verapamil)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Adrenaline or other sympathomimetics (e.g. noradrenaline, dobutamine, epinephrine)
integer
C0014563 (UMLS CUI [1])
C0012963 (UMLS CUI [2])
C0028351 (UMLS CUI [3])
C0205394 (UMLS CUI [4,1])
C0039052 (UMLS CUI [4,2])
Adrenaline or other sympathomimetics (e.g. noradrenaline, dobutamine, epinephrine)
Code List
Adrenaline or other sympathomimetics (e.g. noradrenaline, dobutamine, epinephrine)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Vasopressin (e.g. argipressin, arginine vasopressin)
integer
C0042413 (UMLS CUI [1])
C0003779 (UMLS CUI [2])
Vasopressin (e.g. argipressin, arginine vasopressin)
Code List
Vasopressin (e.g. argipressin, arginine vasopressin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Iloprost
integer
C0079594 (UMLS CUI [1])
Colchicine
Code List
Iloprost
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Nitrates (nitroglycerin, ISMN, Molsidomin, NO)
integer
C3654024 (UMLS CUI [1])
C0017887 (UMLS CUI [2])
C0064079 (UMLS CUI [3])
C0026400 (UMLS CUI [4])
C0028215 (UMLS CUI [5])
Colchicine
Code List
Nitrates (nitroglycerin, ISMN, Molsidomin, NO)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Aviptadil (VIP analog)
integer
C1098515 (UMLS CUI [1])
C0042395 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
Colchicine
Code List
Aviptadil (VIP analog)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Colchicine
integer
C0009262 (UMLS CUI [1])
Colchicine
Code List
Colchicine
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Treatments received, Immune therapy
C0087111 (UMLS CUI-1)
C0279021 (UMLS CUI-2)
Item
Immunoglobulines
integer
C0021027 (UMLS CUI [1])
Immunoglobulines
Code List
Immunoglobulines
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Interferone (any)
integer
C0021747 (UMLS CUI [1])
Interferone (any)
Code List
Interferone (any)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Apheresis therapy
integer
C0005791 (UMLS CUI [1])
Apheresis therapy
Code List
Apheresis therapy
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Vitamin D
integer
C0042866 (UMLS CUI [1])
25-Hydroxyvitamin D
Code List
Vitamin D
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Zinc
integer
C0043481 (UMLS CUI [1])
Zinc
Code List
Zinc
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Convalescent plasma
integer
C0032105 (UMLS CUI [1,1])
C0740326 (UMLS CUI [1,2])
Zinc
Code List
Convalescent plasma
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other COVID-19 related drug therapy
C5203670 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C0205394 (UMLS CUI-3)
Item
Other COVID-19 related drug therapy
integer
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Other COVID-19 related drug therapy
Code List
Other COVID-19 related drug therapy
CL Item
Yes, please specify (1)
CL Item
No (2)
CL Item
Unknown (3)
Other COVID-19 related drug therapy, specify
Item
If Other COVID-19 related drug therapy, please specify
text
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
Item Group
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Non-oral anticoagulants
C0199242 (UMLS CUI-1)
C0032177 (UMLS CUI-2)
C0003280 (UMLS CUI-3)
C1518896 (UMLS CUI-4)
Item
Heparin, prophylactic dose
integer
C0019134 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0199176 (UMLS CUI [1,3])
Heparin, prophylactic dose
Code List
Heparin, prophylactic dose
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Heparin, therapeutic dose
integer
C0019134 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0302350 (UMLS CUI [1,3])
Heparin, therapeutic dose
Code List
Heparin, therapeutic dose
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Heparin, subtherapeutic dose (but higher than prophylactic dose)
integer
C0019134 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205103 (UMLS CUI [1,3])
C0199176 (UMLS CUI [1,4])
C0302350 (UMLS CUI [1,5])
Heparin, therapeutic dose
Code List
Heparin, subtherapeutic dose (but higher than prophylactic dose)
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), prophylactic dose
integer
C0019139 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0199176 (UMLS CUI [1,3])
C0206460 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0199176 (UMLS CUI [2,3])
C0878354 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0199176 (UMLS CUI [3,3])
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), prophylactic dose
Code List
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), prophylactic dose
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), therapeutic dose
integer
C0019139 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0302350 (UMLS CUI [1,3])
C0206460 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0302350 (UMLS CUI [2,3])
C0878354 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0302350 (UMLS CUI [3,3])
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), therapeutic dose
Code List
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), therapeutic dose
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), subtherapeutic dose (but higher than prophylactic dose)
integer
C0019139 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205103 (UMLS CUI [1,3])
C0199176 (UMLS CUI [1,4])
C0302350 (UMLS CUI [1,5])
C0206460 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205103 (UMLS CUI [2,3])
C0199176 (UMLS CUI [2,4])
C0302350 (UMLS CUI [2,5])
C0878354 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205103 (UMLS CUI [3,3])
C0199176 (UMLS CUI [3,4])
C0302350 (UMLS CUI [3,5])
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), therapeutic dose
Code List
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), subtherapeutic dose (but higher than prophylactic dose)
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Argatroban
integer
C0048470 (UMLS CUI [1])
Low molecular weight heparin (enoxaparin, fraxiparin, etc.), therapeutic dose
Code List
Argatroban
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Oral anticoagulants
C0199242 (UMLS CUI-1)
C0032177 (UMLS CUI-2)
C0354604 (UMLS CUI-3)
Item
Warfarin / marcumar
integer
C0043031 (UMLS CUI [1])
C0918269 (UMLS CUI [2])
Warfarin / marcumar
Code List
Warfarin / marcumar
CL Item
not quoted (0)
CL Item
quoted (1)
Item
New / direct oral anticoagulants (rivaroxaban, apixaban, dabigatran)
integer
C0360593 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
C1739768 (UMLS CUI [2])
C1831808 (UMLS CUI [3])
C2348066 (UMLS CUI [4])
New / direct oral anticoagulants
Code List
New / direct oral anticoagulants (rivaroxaban, apixaban, dabigatran)
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Platelet aggregation inhibition
C0199242 (UMLS CUI-1)
C0032177 (UMLS CUI-2)
Item
Aspirin
integer
C0004057 (UMLS CUI [1])
Aspirin
Code List
Aspirin
CL Item
not quoted (0)
CL Item
quoted (1)
Item
ADP receptor inhibitors (Clopidogrel, Cangrelor, Ticagrelor)
integer
C1373149 (UMLS CUI [1])
C0070166 (UMLS CUI [2])
C1121991 (UMLS CUI [3])
C1999375 (UMLS CUI [4])
ADP receptor inhibitors (Clopidogrel, Cangrelor, Ticagrelor)
Code List
ADP receptor inhibitors (Clopidogrel, Cangrelor, Ticagrelor)
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Glycoprotein IIB/IIIA inhibitors
integer
C1373125 (UMLS CUI [1])
Glycoprotein IIB/IIIA inhibitors
Code List
Glycoprotein IIB/IIIA inhibitors
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Thrombosis prophylaxis / anticoagulation / platelet aggregation inhibition: Further anticoagulation / platelet aggregation inhibition
C0199242 (UMLS CUI-1)
C0003281 (UMLS CUI-2)
C0032177 (UMLS CUI-3)
Item
Other
integer
C0205394 (UMLS CUI [1,1])
C0003280 (UMLS CUI [1,2])
Other
Code List
Other
CL Item
not quoted (0)
CL Item
quoted (1)
Other, specify
Item
If Other, please specify
text
C0205394 (UMLS CUI [1,1])
C0003280 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
None
integer
C0549184 (UMLS CUI [1,1])
C0003281 (UMLS CUI [1,2])
None
Code List
None
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Unknown
integer
C0439673 (UMLS CUI [1,1])
C0003281 (UMLS CUI [1,2])
Unknown
Code List
Unknown
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Vital signs and respiratory parameters
C0518766 (UMLS CUI-1)
C0035237 (UMLS CUI-2)
C0549193 (UMLS CUI-3)
Item
Worst during uncomplicated phase: Systolic BP
integer
C0871470 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (Systolic BP) 17899
Code List
Worst during uncomplicated phase: Systolic BP
CL Item
< 80 mmHg (1)
CL Item
80 - 99 mmHg (2)
CL Item
100 - 119 mmHg (3)
CL Item
120 - 139 mmHg (4)
CL Item
140 - 159 mmHg (5)
CL Item
160 - 179 mmHg (6)
CL Item
> 179 mmHg (7)
CL Item
Not done (8)
CL Item
Unknown (9)
Item
Worst during uncomplicated phase: Diastolic BP
integer
C0428883 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (Diastolic BP) 17900
Code List
Worst during uncomplicated phase: Diastolic BP
CL Item
< 40 mmHg (1)
CL Item
40 - 59 mmHg (2)
CL Item
60 - 89 mmHg (3)
CL Item
90 - 109 mmHg (4)
CL Item
110 - 119 mmHg (5)
CL Item
> 119 mmHg (6)
CL Item
Unknown (7)
CL Item
Unknown (7)
Item
Worst during uncomplicated phase: Pulse
integer
C0232117 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (Pulse) 17901
Code List
Worst during uncomplicated phase: Pulse
CL Item
< 45 bpm (1)
CL Item
45 - 59 bpm (2)
CL Item
60 - 89 bpm (3)
CL Item
90 - 119 bpm (4)
CL Item
> 119 bpm (5)
CL Item
Not done (6)
CL Item
Unknown (7)
Item
Worst during uncomplicated phase: SO2
integer
C0523807 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (SO2) 17902
Code List
Worst during uncomplicated phase: SO2
CL Item
< 60% (1)
CL Item
60 - 69% (2)
CL Item
70 - 79% (3)
CL Item
80 - 89% (4)
CL Item
90 - 95% (5)
CL Item
96 - 100% (6)
CL Item
Not done (7)
CL Item
Unknown (8)
Item
Worst during uncomplicated phase: paO2
integer
C0202155 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (paO2) 17903
Code List
Worst during uncomplicated phase: paO2
CL Item
< 50 mmHg (< 6.66 kPa) (1)
CL Item
50 - 59 mmHg (6.67 - 7.86 kPa) (2)
CL Item
60 - 69 mmHg (7.87 - 9.2 kPa) (3)
CL Item
70 - 79 mmHg (9.21 - 10.53 kPa) (4)
CL Item
> 79 mmHg (> 10.53 kPa) (5)
CL Item
Not done (6)
CL Item
Unknown (7)
Item
Worst during uncomplicated phase: paCO2
integer
C1822070 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (paCO2) 17904
Code List
Worst during uncomplicated phase: paCO2
CL Item
< 30 mmHg (< 4 kPa) (1)
CL Item
30 - 38 mmHg (4 - 5.06 kPa) (2)
CL Item
39 - 45 mmHg (5.07 - 5.99 kPa) (3)
CL Item
46 - 55 mmHg (6 - 7.33 kPa) (4)
CL Item
> 55 mmHg (> 7.33 kPa) (5)
CL Item
Not done (6)
CL Item
Unknown (7)
Item
Worst during uncomplicated phase: Temperature
integer
C0039476 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (Temperature) 17905
Code List
Worst during uncomplicated phase: Temperature
CL Item
< 35.1°C (< 95.2°F) (1)
CL Item
35.1 - 37.2°C (95.2 - 99.0°F) (2)
CL Item
37.3 - 37.9°C (99.1 - 100.2°F) (3)
CL Item
38 - 38.9°C (100.4 - 102.0°F) (4)
CL Item
39 - 39.9°C (102.1 - 103.8°F) (5)
CL Item
> 39.9°C (>103.8 °F) (6)
CL Item
Not done (7)
CL Item
Unknown (8)
Item
Worst during uncomplicated phase: Respiratory rate / minute
integer
C0231832 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (Respiratory rate / minute) 18273
Code List
Worst during uncomplicated phase: Respiratory rate / minute
CL Item
< 16 (1)
CL Item
16-21 (2)
CL Item
22-29 (3)
CL Item
> 29 (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
Worst during uncomplicated phase: Glasgow Coma scale
integer
C0017594 (UMLS CUI [1,1])
C1522166 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Worst during this phase of disease (Glasgow Coma scale)
Code List
Worst during uncomplicated phase: Glasgow Coma scale
CL Item
15 (1)
CL Item
13 - 14 (2)
CL Item
9 - 12 (3)
CL Item
3 - 8 (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Super-Infections
C0038826 (UMLS CUI-1)
Item
Proven bacterial infection:
integer
C0004623 (UMLS CUI [1,1])
C0456369 (UMLS CUI [1,2])
Proven bacterial infection:
Code List
Proven bacterial infection:
CL Item
not quoted (0)
CL Item
quoted (1)
Proven bacterial infection, specify
Item
Proven bacterial infection, please specify:
text
C0004623 (UMLS CUI [1,1])
C0456369 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
Probable or suspected bacterial infection:
integer
C0004623 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
Probable or suspected bacterial infection:
Code List
Probable or suspected bacterial infection:
CL Item
not quoted (0)
CL Item
quoted (1)
Probable or suspected bacterial infection, specify
Item
Probable or suspected bacterial infection, please specify:
text
C0004623 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
Proven fungal infection:
integer
C0026946 (UMLS CUI [1,1])
C0456369 (UMLS CUI [1,2])
Proven fungal infection:
Code List
Proven fungal infection:
CL Item
not quoted (0)
CL Item
quoted (1)
Proven fungal infection, specify
Item
Proven fungal infection, please specify:
text
C0026946 (UMLS CUI [1,1])
C0456369 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
Probable or suspected fungal infection:
integer
C0026946 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
Probable or suspected fungal infection:
Code List
Probable or suspected fungal infection:
CL Item
not quoted (0)
CL Item
quoted (1)
Probable or suspected fungal infection, specify
Item
Probable or suspected fungal infection, please specify:
text
C0026946 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
None
integer
C0549184 (UMLS CUI [1,1])
C0038826 (UMLS CUI [1,2])
None
Code List
None
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Unknown
integer
C0439673 (UMLS CUI [1,1])
C0038826 (UMLS CUI [1,2])
Unknown
Code List
Unknown
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Antibacterial treatment: Betalactams
C0279516 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C0282215 (UMLS CUI-3)
Item
Penicillins/ aminopenicilins
integer
C0030842 (UMLS CUI [1])
C0304324 (UMLS CUI [2])
Penicillins/ aminopenicilins
Code List
Penicillins/ aminopenicilins
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cephalosporins I-III
integer
C0304317 (UMLS CUI [1])
C0304319 (UMLS CUI [2])
C0304320 (UMLS CUI [3])
Penicillins/ aminopenicilins
Code List
Cephalosporins I-III
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Carbapenems (meropenem, imipenem, ertapenem, doripenem)
integer
C0006968 (UMLS CUI [1])
C0066005 (UMLS CUI [2])
C0020933 (UMLS CUI [3])
C1120106 (UMLS CUI [4])
C0389169 (UMLS CUI [5])
Penicillins/ aminopenicilins
Code List
Carbapenems (meropenem, imipenem, ertapenem, doripenem)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Piperacillin/tazobactam
integer
C0250480 (UMLS CUI [1])
Penicillins/ aminopenicilins
Code List
Piperacillin/tazobactam
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
New betalactams for multi-resistent bacteria (ceftazidime/avibactam, ceftolozane/tazobactam, cefiderocol)
integer
C0205314 (UMLS CUI [1,1])
C0282215 (UMLS CUI [1,2])
C3826980 (UMLS CUI [1,3])
C3656596 (UMLS CUI [2])
C3656593 (UMLS CUI [3])
C4548369 (UMLS CUI [4])
Penicillins/ aminopenicilins
Code List
New betalactams for multi-resistent bacteria (ceftazidime/avibactam, ceftolozane/tazobactam, cefiderocol)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibacterial treatment: Macrolides
C0279516 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C0003240 (UMLS CUI-3)
Item
Azithromycin
integer
C0052796 (UMLS CUI [1])
Azithromycin
Code List
Azithromycin
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other macrolide (erythromycin, clarithromycin, roxithromycin)
integer
C0003240 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0014806 (UMLS CUI [2])
C0055856 (UMLS CUI [3])
C0035891 (UMLS CUI [4])
Azithromycin
Code List
Other macrolide (erythromycin, clarithromycin, roxithromycin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibacterial treatment: Other antibacterial treatment
C0279516 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C0205394 (UMLS CUI-3)
Item
Glycopeptides (vancomycin, teicoplanin)
integer
C0017953 (UMLS CUI [1])
C0042313 (UMLS CUI [2])
C0145106 (UMLS CUI [3])
Glycopeptides (vancomycin, teicoplanin)
Code List
Glycopeptides (vancomycin, teicoplanin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other gram-positive active drugs for multiresistant bacteria (e.g. linezolid, daptomycin)
integer
C0205394 (UMLS CUI [1,1])
C00032332 (UMLS CUI [1,2])
C0018154 (UMLS CUI [1,3])
C3826980 (UMLS CUI [1,4])
C0663241 (UMLS CUI [2])
C0057144 (UMLS CUI [3])
Glycopeptides (vancomycin, teicoplanin)
Code List
Other gram-positive active drugs for multiresistant bacteria (e.g. linezolid, daptomycin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
integer
C0034428 (UMLS CUI [1])
C0008809 (UMLS CUI [2])
C0536495 (UMLS CUI [3])
C0282386 (UMLS CUI [4])
Glycopeptides (vancomycin, teicoplanin)
Code List
Fluorochinolones (ciprofloxacin, moxifloxacin, levofloxacin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other
integer
C0279516 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Glycopeptides (vancomycin, teicoplanin)
Code List
Other
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
If Other, please specify
text
C0279516 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
Glycopeptides (vancomycin, teicoplanin)
Code List
If Other, please specify
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Item
Is data entry for this section finished?
integer
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
BL_Completed
Code List
Is data entry for this section finished?
CL Item
Yes (1)
CL Item
No (2)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial